25 XP   0   0   10

Agenus Inc
Buy, Hold or Sell?

Let's analyse Agenus Inc together

PenkeI guess you are interested in Agenus Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Agenus Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Agenus Inc

I send you an email if I find something interesting about Agenus Inc.

Quick analysis of Agenus Inc (30 sec.)










What can you expect buying and holding a share of Agenus Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$-0.35
Expected worth in 1 year
$-0.58
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.22
Return On Investment
-4.5%

For what price can you sell your share?

Current Price per Share
$4.97
Expected price per share
$2.9341 - $
How sure are you?
50%

1. Valuation of Agenus Inc (5 min.)




Live pricePrice per Share (EOD)

$4.97

Intrinsic Value Per Share

$-3.77 - $-2.00

Total Value Per Share

$-4.13 - $-2.35

2. Growth of Agenus Inc (5 min.)




Is Agenus Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$148.3m-$6.3m-$92m-93.5%

How much money is Agenus Inc making?

Current yearPrevious yearGrowGrow %
Making money-$62.4m-$71.5m$9.1m14.6%
Net Profit Margin-224.4%-289.5%--

How much money comes from the company's main activities?

3. Financial Health of Agenus Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#1004 / 1016

Most Revenue
#178 / 1016

Most Profit
#922 / 1016

Most Efficient
#655 / 1016

What can you expect buying and holding a share of Agenus Inc? (5 min.)

Welcome investor! Agenus Inc's management wants to use your money to grow the business. In return you get a share of Agenus Inc.

What can you expect buying and holding a share of Agenus Inc?

First you should know what it really means to hold a share of Agenus Inc. And how you can make/lose money.

Speculation

The Price per Share of Agenus Inc is $4.97. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Agenus Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Agenus Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.35. Based on the TTM, the Book Value Change Per Share is $-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Agenus Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.11-2.2%-0.15-3.0%-0.13-2.6%-0.09-1.9%-0.08-1.6%
Usd Book Value Change Per Share-0.08-1.6%-0.06-1.1%-0.06-1.2%0.000.1%-0.01-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.2%
Usd Total Gains Per Share-0.08-1.6%-0.06-1.1%-0.06-1.2%0.000.1%0.000.1%
Usd Price Per Share0.83-1.26-2.17-2.79-3.42-
Price to Earnings Ratio-1.87--2.12--4.22--3.97-9.04-
Price-to-Total Gains Ratio-10.48-74.32--40.71--0.26-124.41-
Price to Book Ratio-2.34--6.74-1.47--0.19-5.48-
Price-to-Total Gains Ratio-10.48-74.32--40.71--0.26-124.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.97
Number of shares201
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.060.00
Usd Total Gains Per Share-0.060.00
Gains per Quarter (201 shares)-11.170.64
Gains per Year (201 shares)-44.692.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-45-5503-7
20-90-10005-4
30-135-14508-1
41-179-1900102
51-224-2350135
61-269-2800158
71-314-32501811
81-359-37002014
91-404-41502317
102-449-46002520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%3.037.00.07.5%6.090.00.06.3%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%12.028.00.030.0%31.065.00.032.3%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.019.05.0%4.00.036.010.0%41.00.055.042.7%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%12.028.00.030.0%32.064.00.033.3%

Fundamentals of Agenus Inc

About Agenus Inc

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an antigen 4 (CTLA-4) blocking antibody that is in Phase 2 clinical trial for the treatment of pancreatic cancer and and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in Phase 1 clinical trial; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monospecific antibody; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract that is in a Phase 1 clinical trial; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. The company operates under Agenus, MiNK, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., Incyte Corporation, Merck Sharpe & Dohme, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-10 23:55:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Agenus Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Agenus Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -55.2% means that $-0.55 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Agenus Inc:

  • The MRQ is -55.2%. The company is making a huge loss. -2
  • The TTM is -224.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-55.2%TTM-224.4%+169.2%
TTM-224.4%YOY-289.5%+65.1%
TTM-224.4%5Y-254.7%+30.3%
5Y-254.7%10Y-454.2%+199.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.2%-199.6%+144.4%
TTM-224.4%-213.0%-11.4%
YOY-289.5%-279.3%-10.2%
5Y-254.7%-438.4%+183.7%
10Y-454.2%-605.5%+151.3%
1.1.2. Return on Assets

Shows how efficient Agenus Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • -14.7% Return on Assets means that Agenus Inc generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Agenus Inc:

  • The MRQ is -14.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.7%TTM-17.2%+2.5%
TTM-17.2%YOY-16.6%-0.6%
TTM-17.2%5Y-16.5%-0.7%
5Y-16.5%10Y-17.5%+1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.7%-13.5%-1.2%
TTM-17.2%-12.9%-4.3%
YOY-16.6%-11.8%-4.8%
5Y-16.5%-14.1%-2.4%
10Y-17.5%-16.0%-1.5%
1.1.3. Return on Equity

Shows how efficient Agenus Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Agenus Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Agenus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-475.0%+475.0%
TTM-5Y-83.2%+83.2%
5Y-83.2%10Y-59.1%-24.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-475.0%-15.1%-459.9%
5Y-83.2%-19.9%-63.3%
10Y-59.1%-20.9%-38.2%

1.2. Operating Efficiency of Agenus Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Agenus Inc is operating .

  • Measures how much profit Agenus Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • An Operating Margin of -5.2% means the company generated $-0.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Agenus Inc:

  • The MRQ is -5.2%. The company is operating very inefficient. -2
  • The TTM is -161.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5.2%TTM-161.0%+155.8%
TTM-161.0%YOY-184.0%+23.0%
TTM-161.0%5Y-173.9%+13.0%
5Y-173.9%10Y-356.9%+182.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.2%-295.1%+289.9%
TTM-161.0%-225.8%+64.8%
YOY-184.0%-288.4%+104.4%
5Y-173.9%-477.4%+303.5%
10Y-356.9%-625.6%+268.7%
1.2.2. Operating Ratio

Measures how efficient Agenus Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are $1.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Agenus Inc:

  • The MRQ is 1.052. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.627. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.052TTM2.627-1.575
TTM2.627YOY2.849-0.222
TTM2.6275Y2.753-0.125
5Y2.75310Y4.654-1.901
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0523.090-2.038
TTM2.6273.264-0.637
YOY2.8493.783-0.934
5Y2.7535.679-2.926
10Y4.6547.894-3.240

1.3. Liquidity of Agenus Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Agenus Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.44 means the company has $0.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Agenus Inc:

  • The MRQ is 0.439. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.747. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.439TTM0.747-0.307
TTM0.747YOY1.543-0.796
TTM0.7475Y1.124-0.378
5Y1.12410Y2.337-1.213
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4393.914-3.475
TTM0.7474.220-3.473
YOY1.5435.388-3.845
5Y1.1246.045-4.921
10Y2.3376.406-4.069
1.3.2. Quick Ratio

Measures if Agenus Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.40 means the company can pay off $0.40 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Agenus Inc:

  • The MRQ is 0.398. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.729. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.398TTM0.729-0.331
TTM0.729YOY1.467-0.738
TTM0.7295Y1.048-0.318
5Y1.04810Y2.501-1.453
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3983.572-3.174
TTM0.7293.998-3.269
YOY1.4675.390-3.923
5Y1.0485.969-4.921
10Y2.5016.287-3.786

1.4. Solvency of Agenus Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Agenus Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Agenus Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.47 means that Agenus Inc assets are financed with 147.3% credit (debt) and the remaining percentage (100% - 147.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Agenus Inc:

  • The MRQ is 1.473. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.286. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.473TTM1.286+0.186
TTM1.286YOY1.017+0.269
TTM1.2865Y1.573-0.287
5Y1.57310Y1.325+0.248
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4730.336+1.137
TTM1.2860.334+0.952
YOY1.0170.269+0.748
5Y1.5730.366+1.207
10Y1.3250.390+0.935
1.4.2. Debt to Equity Ratio

Measures if Agenus Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Agenus Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY38.966-38.966
TTM-5Y8.881-8.881
5Y8.88110Y5.643+3.238
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.382-0.382
TTM-0.396-0.396
YOY38.9660.335+38.631
5Y8.8810.434+8.447
10Y5.6430.465+5.178

2. Market Valuation of Agenus Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Agenus Inc generates.

  • Above 15 is considered overpriced but always compare Agenus Inc to the Biotechnology industry mean.
  • A PE ratio of -1.87 means the investor is paying $-1.87 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Agenus Inc:

  • The EOD is -11.245. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.873. Based on the earnings, the company is expensive. -2
  • The TTM is -2.122. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.245MRQ-1.873-9.371
MRQ-1.873TTM-2.122+0.249
TTM-2.122YOY-4.216+2.094
TTM-2.1225Y-3.970+1.847
5Y-3.97010Y9.038-13.007
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.245-2.259-8.986
MRQ-1.873-2.569+0.696
TTM-2.122-2.664+0.542
YOY-4.216-4.120-0.096
5Y-3.970-6.258+2.288
10Y9.038-6.171+15.209
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Agenus Inc:

  • The EOD is -14.775. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.461. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.549. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.775MRQ-2.461-12.314
MRQ-2.461TTM-2.549+0.088
TTM-2.549YOY-4.014+1.465
TTM-2.5495Y-5.675+3.126
5Y-5.67510Y-9.277+3.602
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.775-2.924-11.851
MRQ-2.461-3.246+0.785
TTM-2.549-3.488+0.939
YOY-4.014-5.620+1.606
5Y-5.675-8.315+2.640
10Y-9.277-8.826-0.451
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Agenus Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -2.34 means the investor is paying $-2.34 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Agenus Inc:

  • The EOD is -14.032. Based on the equity, the company is expensive. -2
  • The MRQ is -2.337. Based on the equity, the company is expensive. -2
  • The TTM is -6.735. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.032MRQ-2.337-11.694
MRQ-2.337TTM-6.735+4.398
TTM-6.735YOY1.470-8.205
TTM-6.7355Y-0.188-6.548
5Y-0.18810Y5.482-5.669
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.0321.851-15.883
MRQ-2.3372.090-4.427
TTM-6.7352.095-8.830
YOY1.4702.844-1.374
5Y-0.1883.466-3.654
10Y5.4823.815+1.667
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Agenus Inc.

3.1. Institutions holding Agenus Inc

Institutions are holding 59.029% of the shares of Agenus Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc7.69510.000732236488384333813.5361
2023-12-31Deep Track Capital, LP7.56650.87643169753900
2023-12-31Vanguard Group Inc7.2250.000630266890332845112.3558
2023-09-30Point72 Asset Management, L.P.4.20510.058117615811-1172-0.0067
2023-12-31Sofinnova Ventures3.73730.725315656234229148617.1457
2023-12-31Artal Group S A3.73130.43021563123500
2023-12-31State Street Corporation2.07210.00048680267-12249337-58.5264
2023-12-31Millennium Management LLC2.00110.00383829517132035570.145
2023-12-31Geode Capital Management, LLC1.88760.0007790756179275711.1424
2023-09-30BRAIDWELL LP1.50550.22526307030160910034.2513
2023-12-31Renaissance Technologies Corp1.44050.007760344155414073872.7562
2023-12-31Goldman Sachs Group Inc1.38150.000457872343430414145.5527
2023-12-31Qube Research & Technologies0.94510.0064395906839590680
2023-12-31Northern Trust Corp0.83120.000534820421368764.0918
2023-12-31Charles Schwab Investment Management Inc0.65240.000627328531022943.8887
2023-12-31Morgan Stanley - Brokerage Accounts0.61790.0002258869757932928.8314
2023-12-31GSA Capital Partners LLP0.57280.1671239973222792431891.6606
2023-12-31Assenagon Asset Management SA0.55050.0051230624822320643008.8213
2023-12-31Readystate Asset Management LP0.48140.0568201678325212414.2874
2023-12-31UBS O'Connor LLC0.38870.097162839418431612.7636
Total 49.48862.6624207317472+25316459+12.2%

3.2. Funds holding Agenus Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.11770.0004986294500
2024-03-28iShares Russell 2000 ETF0.11260.0084943184745480.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.06240.0034522977400
2023-12-31Vanguard Strategic Equity Inv0.04840.0431405752900
2024-01-31Fidelity Small Cap Index0.04580.01033835001636501.6877
2023-12-31Vanguard Explorer Inv0.04530.0147379833496716534.1613
2024-03-28iShares Russell 2000 Value ETF0.03640.01413050011-1934-0.0634
2024-03-31Selectra J. Lamarck Biotech A0.03441.5688287805400
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.02720.00372279887280001.2434
2023-12-31Vanguard VIF Small Co Gr0.02010.092416876431108275191.2903
2024-03-29Schwab US Small-Cap ETF™0.01910.0054160104000
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.01880.0877157772460800862.6996
2024-02-29Fidelity Extended Market Index0.01710.00251430299-470987-24.772
2024-02-29Vanguard Russell 2000 ETF0.01660.009813878801084858.4794
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.01550.0077129818600
2023-12-31BIT Global Leaders I - I0.01471.7607122810500
2023-12-31NT R2000 Index Fund - NL0.01270.01221066554578955.7398
2024-02-29Vanguard Health Care ETF0.01250.00341046162-60981-5.508
2024-03-31BlackRock Extended Equity Market K0.01180.003998878726434836.49
2023-12-31NT R2000 Value Index Fund - NL0.0110.0202922126569146.578
Total 0.70013.672858657888+2733386+4.7%

3.3. Insider Transactions

Insiders are holding 1.197% of the shares of Agenus Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-15Garo H ArmenBUY5000000.65
2023-10-16Agenus IncBUY4291.1
2023-10-12Agenus IncBUY31731.1
2023-10-04Agenus IncBUY150011.09
2023-08-28Agenus IncBUY128081.45
2023-08-24Agenus IncBUY1702441.54
2023-05-10Agenus IncBUY220651.51
2023-05-05Agenus IncBUY1002000.95
2023-05-03Agenus IncBUY1286891.08

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Agenus Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.079-0.056-29%-0.061-22%0.003-2629%-0.009-89%
Book Value Per Share---0.354-0.235-34%-0.015-96%-0.281-21%-0.152-57%
Current Ratio--0.4390.747-41%1.543-72%1.124-61%2.337-81%
Debt To Asset Ratio--1.4731.286+14%1.017+45%1.573-6%1.325+11%
Debt To Equity Ratio----0%38.966-100%8.881-100%5.643-100%
Dividend Per Share---0.000-100%-0%0.000-100%0.012-100%
Eps---0.110-0.147+33%-0.131+19%-0.093-16%-0.080-28%
Free Cash Flow Per Share---0.084-0.127+51%-0.136+62%-0.075-10%-0.063-26%
Free Cash Flow To Equity Per Share---0.067-0.056-16%-0.079+19%0.003-2339%0.003-2047%
Gross Profit Margin--1.1121.028+8%1.000+11%1.006+11%1.003+11%
Intrinsic Value_10Y_max---1.997--------
Intrinsic Value_10Y_min---3.773--------
Intrinsic Value_1Y_max---0.243--------
Intrinsic Value_1Y_min---0.374--------
Intrinsic Value_3Y_max---0.698--------
Intrinsic Value_3Y_min---1.134--------
Intrinsic Value_5Y_max---1.113--------
Intrinsic Value_5Y_min---1.899--------
Market Cap2082032400.000+83%346823868.000528834135.000-34%909527685.000-62%1168633894.200-70%1434551742.600-76%
Net Profit Margin---0.552-2.244+306%-2.895+424%-2.547+361%-4.542+722%
Operating Margin---0.052-1.610+2994%-1.840+3437%-1.739+3244%-3.569+6761%
Operating Ratio--1.0522.627-60%2.849-63%2.753-62%4.654-77%
Pb Ratio-14.032-500%-2.337-6.735+188%1.470-259%-0.188-92%5.482-143%
Pe Ratio-11.245-500%-1.873-2.122+13%-4.216+125%-3.970+112%9.038-121%
Price Per Share4.970+83%0.8281.262-34%2.171-62%2.790-70%3.424-76%
Price To Free Cash Flow Ratio-14.775-500%-2.461-2.549+4%-4.014+63%-5.675+131%-9.277+277%
Price To Total Gains Ratio-62.920-500%-10.48174.322-114%-40.706+288%-0.255-98%124.408-108%
Quick Ratio--0.3980.729-45%1.467-73%1.048-62%2.501-84%
Return On Assets---0.147-0.172+17%-0.166+13%-0.165+12%-0.175+18%
Return On Equity----0%-4.7500%-0.8320%-0.5910%
Total Gains Per Share---0.079-0.056-30%-0.061-22%0.003-2598%0.004-2160%
Usd Book Value---148382000.000-98386000.000-34%-6362500.000-96%-117631000.000-21%-63643529.675-57%
Usd Book Value Change Per Share---0.079-0.056-29%-0.061-22%0.003-2629%-0.009-89%
Usd Book Value Per Share---0.354-0.235-34%-0.015-96%-0.281-21%-0.152-57%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.012-100%
Usd Eps---0.110-0.147+33%-0.131+19%-0.093-16%-0.080-28%
Usd Free Cash Flow---35229000.000-53300000.000+51%-57108750.000+62%-31560250.000-10%-26188594.950-26%
Usd Free Cash Flow Per Share---0.084-0.127+51%-0.136+62%-0.075-10%-0.063-26%
Usd Free Cash Flow To Equity Per Share---0.067-0.056-16%-0.079+19%0.003-2339%0.003-2047%
Usd Market Cap2082032400.000+83%346823868.000528834135.000-34%909527685.000-62%1168633894.200-70%1434551742.600-76%
Usd Price Per Share4.970+83%0.8281.262-34%2.171-62%2.790-70%3.424-76%
Usd Profit---46290000.000-62442250.000+35%-71562000.000+55%-42425700.000-8%-34649558.825-25%
Usd Revenue--83801000.00039078250.000+114%24506250.000+242%39410850.000+113%23056104.275+263%
Usd Total Gains Per Share---0.079-0.056-30%-0.061-22%0.003-2598%0.004-2160%
 EOD+6 -2MRQTTM+13 -21YOY+18 -155Y+10 -2510Y+10 -25

4.2. Fundamental Score

Let's check the fundamental score of Agenus Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.245
Price to Book Ratio (EOD)Between0-1-14.032
Net Profit Margin (MRQ)Greater than0-0.552
Operating Margin (MRQ)Greater than0-0.052
Quick Ratio (MRQ)Greater than10.398
Current Ratio (MRQ)Greater than10.439
Debt to Asset Ratio (MRQ)Less than11.473
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.147
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Agenus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.532
Ma 20Greater thanMa 501.957
Ma 50Greater thanMa 1001.191
Ma 100Greater thanMa 2000.953
OpenGreater thanClose5.360
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  -100,24623,178-77,06821,210-55,85838,575-17,283291,419274,136
Gross Profit  -32,586-3,924-36,5102,267-34,2436,811-27,432105,77278,340
EBITDA  -52,816671-52,1451,343-50,8027,755-43,04743,889842



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets313,913
Total Liabilities462,295
Total Stockholder Equity-160,331
 As reported
Total Liabilities 462,295
Total Stockholder Equity+ -160,331
Total Assets = 313,913

Assets

Total Assets313,913
Total Current Assets112,416
Long-term Assets201,497
Total Current Assets
Cash And Cash Equivalents 76,110
Net Receivables 25,836
Other Current Assets 10,470
Total Current Assets  (as reported)112,416
Total Current Assets  (calculated)112,416
+/-0
Long-term Assets
Property Plant Equipment 163,027
Goodwill 24,723
Intangible Assets 4,411
Long-term Assets Other 5,667
Long-term Assets  (as reported)201,497
Long-term Assets  (calculated)197,828
+/- 3,669

Liabilities & Shareholders' Equity

Total Current Liabilities255,897
Long-term Liabilities206,398
Total Stockholder Equity-160,331
Total Current Liabilities
Short-term Debt 145,692
Short Long Term Debt 146
Accounts payable 61,446
Other Current Liabilities 48,741
Total Current Liabilities  (as reported)255,897
Total Current Liabilities  (calculated)256,025
+/- 128
Long-term Liabilities
Long term Debt 12,768
Capital Lease Obligations 65,098
Long-term Liabilities Other 129,976
Long-term Liabilities  (as reported)206,398
Long-term Liabilities  (calculated)207,842
+/- 1,444
Total Stockholder Equity
Common Stock3,944
Retained Earnings -1,955,668
Accumulated Other Comprehensive Income -955
Other Stockholders Equity 1,792,348
Total Stockholder Equity (as reported)-160,331
Total Stockholder Equity (calculated)-160,331
+/-0
Other
Capital Stock3,944
Cash and Short Term Investments 76,110
Common Stock Shares Outstanding 394,373
Current Deferred Revenue18
Liabilities and Stockholders Equity 313,913
Net Debt 274,136
Net Invested Capital -147,417
Net Working Capital -143,481
Property Plant and Equipment Gross 224,970
Short Long Term Debt Total 350,246



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
119,024
115,191
112,098
127,966
119,251
111,872
105,612
93,546
136,490
117,820
103,998
89,063
135,235
122,120
152,442
140,080
180,905
167,830
152,091
133,058
161,983
142,559
121,721
104,151
84,019
69,130
59,679
72,952
62,967
55,236
52,636
44,537
60,218
72,140
62,503
56,945
46,711
39,687
51,350
45,874
39,120
42,106
36,616
30,907
26,427
22,231
24,369
19,808
33,205
33,269
32,224
34,673
30,713
21,371
37,670
34,835
108,304
100,188
87,632
74,527
117,324
180,110
242,608
242,228
221,139
196,454
174,842
156,986
203,269
176,491
149,270
138,402
130,816
131,936
130,475
136,401
245,933
206,707
174,807
155,335
180,055
185,784
204,483
214,514
234,915
192,299
437,639
465,958
441,305
456,174
429,019
413,556
412,854
383,593
335,472
313,913
313,913335,472383,593412,854413,556429,019456,174441,305465,958437,639192,299234,915214,514204,483185,784180,055155,335174,807206,707245,933136,401130,475131,936130,816138,402149,270176,491203,269156,986174,842196,454221,139242,228242,608180,110117,32474,52787,632100,188108,30434,83537,67021,37130,71334,67332,22433,26933,20519,80824,36922,23126,42730,90736,61642,10639,12045,87451,35039,68746,71156,94562,50372,14060,21844,53752,63655,23662,96772,95259,67969,13084,019104,151121,721142,559161,983133,058152,091167,830180,905140,080152,442122,120135,23589,063103,998117,820136,49093,546105,612111,872119,251127,966112,098115,191119,024
   > Total Current Assets 
110,508
106,221
102,743
101,593
93,082
85,825
75,505
63,987
106,314
88,392
75,812
63,400
108,107
87,384
107,387
93,322
138,853
127,580
112,464
92,604
120,450
102,277
82,778
66,962
48,933
35,360
27,151
42,298
35,155
28,784
27,123
20,782
37,794
50,825
42,349
35,486
26,396
23,274
35,967
31,533
26,400
30,298
25,635
20,854
16,914
13,296
15,985
12,004
25,952
26,477
24,758
22,615
18,346
14,446
30,876
28,175
75,260
67,032
55,219
42,670
85,154
146,283
208,943
184,095
161,613
136,069
109,526
91,312
137,950
110,690
84,344
73,554
65,193
67,705
67,636
74,808
179,123
138,938
107,186
86,536
102,774
104,759
125,451
113,783
135,663
92,854
308,401
331,974
290,483
288,934
251,432
213,122
205,689
170,735
125,550
112,416
112,416125,550170,735205,689213,122251,432288,934290,483331,974308,40192,854135,663113,783125,451104,759102,77486,536107,186138,938179,12374,80867,63667,70565,19373,55484,344110,690137,95091,312109,526136,069161,613184,095208,943146,28385,15442,67055,21967,03275,26028,17530,87614,44618,34622,61524,75826,47725,95212,00415,98513,29616,91420,85425,63530,29826,40031,53335,96723,27426,39635,48642,34950,82537,79420,78227,12328,78435,15542,29827,15135,36048,93366,96282,778102,277120,45092,604112,464127,580138,85393,322107,38787,384108,10763,40075,81288,392106,31463,98775,50585,82593,082101,593102,743106,221110,508
       Cash And Cash Equivalents 
109,389
105,141
101,553
96,143
90,078
81,622
71,748
60,867
102,743
55,919
43,595
33,130
70,838
59,022
77,892
57,212
72,244
48,355
37,477
15,980
40,588
42,255
35,783
33,217
26,745
19,415
15,515
24,219
20,938
22,851
21,614
14,479
35,410
39,087
30,919
24,469
14,592
16,059
29,011
20,067
13,940
18,746
14,408
19,782
10,631
12,016
14,732
10,748
24,585
25,456
24,758
21,468
17,214
13,445
30,205
27,352
73,491
62,815
38,386
40,224
79,304
139,642
199,133
171,668
148,230
123,293
95,399
76,437
113,864
96,766
65,075
60,187
52,348
43,164
46,169
53,054
158,306
121,717
93,274
61,808
92,284
79,171
114,144
99,871
119,366
73,543
256,529
291,931
247,709
228,385
208,354
178,674
164,819
143,205
106,305
76,110
76,110106,305143,205164,819178,674208,354228,385247,709291,931256,52973,543119,36699,871114,14479,17192,28461,80893,274121,717158,30653,05446,16943,16452,34860,18765,07596,766113,86476,43795,399123,293148,230171,668199,133139,64279,30440,22438,38662,81573,49127,35230,20513,44517,21421,46824,75825,45624,58510,74814,73212,01610,63119,78214,40818,74613,94020,06729,01116,05914,59224,46930,91939,08735,41014,47921,61422,85120,93824,21915,51519,41526,74533,21735,78342,25540,58815,98037,47748,35572,24457,21277,89259,02270,83833,13043,59555,919102,74360,86771,74881,62290,07896,143101,553105,141109,389
       Short-term Investments 
0
0
0
2,997
2,997
0
0
0
0
28,478
26,868
25,595
32,227
24,686
25,820
32,266
59,675
69,129
68,790
70,941
73,476
54,315
41,436
28,531
17,714
12,452
8,874
15,876
11,336
2,587
3,250
4,200
4,200
9,963
9,955
9,994
9,993
4,998
4,998
9,998
9,997
9,996
9,997
0
4,999
0
0
0
0
0
0
0
0
0
0
0
0
14,545
14,521
14,510
14,510
14,977
14,994
34,965
69,899
49,895
19,961
4,989
9,960
14,936
4,976
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,999
14,992
14,978
9,945
9,876
14,684
24,414
14,647
0
0
0014,64724,41414,6849,8769,94514,97814,9924,9990000000000000004,97614,9369,9604,98919,96149,89569,89934,96514,99414,97714,51014,51014,52114,5450000000000004,99909,9979,9969,9979,9984,9984,9989,9939,9949,9559,9634,2004,2003,2502,58711,33615,8768,87412,45217,71428,53141,43654,31573,47670,94168,79069,12959,67532,26625,82024,68632,22725,59526,86828,47800002,9972,997000
       Net Receivables 
0
0
0
533
865
1,121
693
487
641
558
862
1,116
1,219
543
800
590
324
1
18
76
105
104
4,945
46
3,989
2,935
122
182
377
166
324
319
308
3
870
610
1,055
443
325
752
307
18
35
35
865
0
772
536
59
92
369
552
164
202
1
1
1
1,133
1,430
1,248
2,534
4,111
7,332
9,800
10,224
9,417
10,284
11,352
6,775
3,944
2,191
1,134
1,129
10,920
6,069
938
796
2,205
2,328
16,293
2,643
16,628
1,414
1,157
2,173
1,436
21,773
1,518
1,286
18,994
8,823
2,741
1,417
1,341
1,030
25,836
25,8361,0301,3411,4172,7418,82318,9941,2861,51821,7731,4362,1731,1571,41416,6282,64316,2932,3282,2057969386,06910,9201,1291,1342,1913,9446,77511,35210,2849,41710,2249,8007,3324,1112,5341,2481,4301,133111202164552369925953677208653535183077523254431,05561087033083193241663771821222,9353,989464,945104105761813245908005431,2191,1168625586414876931,121865533000
       Other Current Assets 
1,119
1,080
1,190
1,251
444
775
402
620
462
842
1,380
889
819
433
347
483
691
5,023
3,901
647
539
455
410
291
288
250
432
275
203
1,258
250
436
297
363
379
187
529
534
694
392
974
587
415
306
394
422
455
700
485
218
15
32
65
56
12
163
444
2,989
786
1,103
747
619
437
582
289
507
726
839
635
951
1,237
1,082
598
650
812
1,496
1,851
1,409
1,088
1,015
918
1,296
1,661
2,009
3,446
4,247
6,758
3,171
4,780
2,988
2,390
3,194
3,896
2,843
2,329
10,470
10,4702,3292,8433,8963,1942,3902,9884,7803,1716,7584,2473,4462,0091,6611,2969181,0151,0881,4091,8511,4968126505981,0821,2379516358397265072895824376197471,1037862,98944416312566532152184857004554223943064155879743926945345291873793632974362501,2582032754322502882914104555396473,9015,0236914833474338198891,3808424626204027754441,2511,1901,0801,119
   > Long-term Assets 
8,516
8,970
9,355
26,373
26,169
26,047
30,107
29,559
30,176
29,428
28,186
25,663
27,128
34,736
45,055
46,758
42,052
40,250
39,627
40,454
41,533
40,282
38,943
37,189
35,086
33,770
32,528
30,653
27,812
26,452
25,512
23,755
22,424
21,315
20,154
21,459
20,315
16,413
15,384
14,341
12,721
11,808
10,981
10,052
9,513
8,936
8,384
7,803
7,253
6,792
7,466
9,084
6,787
6,925
6,794
9,446
33,044
33,156
32,413
31,857
32,170
33,826
33,664
58,133
59,526
60,386
65,315
65,674
65,318
65,801
64,927
82,201
65,623
64,232
62,839
61,593
66,810
67,769
67,621
68,799
77,281
81,025
79,032
100,731
99,252
99,445
129,238
133,984
150,822
167,240
177,587
200,434
207,165
212,858
209,922
201,497
201,497209,922212,858207,165200,434177,587167,240150,822133,984129,23899,44599,252100,73179,03281,02577,28168,79967,62167,76966,81061,59362,83964,23265,62382,20164,92765,80165,31865,67465,31560,38659,52658,13333,66433,82632,17031,85732,41333,15633,0449,4466,7946,9256,7879,0847,4666,7927,2537,8038,3848,9369,51310,05210,98111,80812,72114,34115,38416,41320,31521,45920,15421,31522,42423,75525,51226,45227,81230,65332,52833,77035,08637,18938,94340,28241,53340,45439,62740,25042,05246,75845,05534,73627,12825,66328,18629,42830,17629,55930,10726,04726,16926,3739,3558,9708,516
       Property Plant Equipment 
8,068
8,229
8,624
14,640
14,399
14,404
14,293
13,934
14,906
14,212
13,425
11,370
12,903
20,674
24,651
25,033
24,877
24,081
24,396
24,988
25,134
25,000
24,453
23,350
21,627
20,645
19,512
18,619
17,603
16,594
15,581
14,604
13,629
12,876
12,260
11,535
10,828
10,131
9,432
8,891
8,220
7,518
6,878
6,194
5,664
5,095
4,714
4,137
3,586
3,108
2,750
5,212
2,915
2,897
2,887
5,570
4,136
4,543
5,228
5,997
5,880
6,952
7,830
15,311
16,588
18,224
23,508
25,634
25,461
25,575
25,635
26,179
27,036
26,922
25,839
25,116
31,039
32,105
32,713
33,690
42,530
43,535
41,702
60,270
60,734
60,992
81,525
91,083
105,919
127,158
138,854
164,286
171,463
173,886
169,697
163,027
163,027169,697173,886171,463164,286138,854127,158105,91991,08381,52560,99260,73460,27041,70243,53542,53033,69032,71332,10531,03925,11625,83926,92227,03626,17925,63525,57525,46125,63423,50818,22416,58815,3117,8306,9525,8805,9975,2284,5434,1365,5702,8872,8972,9155,2122,7503,1083,5864,1374,7145,0955,6646,1946,8787,5188,2208,8919,43210,13110,82811,53512,26012,87613,62914,60415,58116,59417,60318,61919,51220,64521,62723,35024,45325,00025,13424,98824,39624,08124,87725,03324,65120,67412,90311,37013,42514,21214,90613,93414,29314,40414,39914,6408,6248,2298,068
       Goodwill 
0
0
0
2,962
0
0
0
2,756
3,082
3,082
3,082
3,081,703
3,082
3,082
3,082
3,081,703
3,082
3,082
3,081,703
2,572,203
2,572
2,572
2,572
2,572,203
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
19,636
19,551
18,482
17,869
18,269
18,774
18,140
22,793
23,268
23,015
23,165
22,392
22,668
23,352
23,079
23,049
23,398
22,814
22,959
22,925
22,751
23,034
22,757
23,188
23,264
24,276
24,694
25,452
24,334
24,706
24,528
24,876
24,617
24,438
23,936
25,467
25,623
24,728
24,666
24,723
24,72324,66624,72825,62325,46723,93624,43824,61724,87624,52824,70624,33425,45224,69424,27623,26423,18822,75723,03422,75122,92522,95922,81423,39823,04923,07923,35222,66822,39223,16523,01523,26822,79318,14018,77418,26917,86918,48219,55119,6362,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,572,2032,5722,5722,5722,572,2033,081,7033,0823,0823,081,7033,0823,0823,0823,081,7033,0823,0823,0822,7560002,962000
       Intangible Assets 
0
0
0
2,962
9,334
9,062
13,345
2,756
12,991
12,722
12,453
3,082
11,876
11,599
11,323
11,046
10,770
3,082
3,082
9,428
9,151
8,874
8,598
2,594
5,472
5,195
4,918
4,641
4,364
4,088
3,811
3,534
3,257
2,980
2,704
3,267
2,150
1,873
1,596
1,613
413
258
103
30
30
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
7,998
7,812
7,183
6,774
6,815
6,895
6,490
18,759
18,388
17,724
17,218
16,365
15,907
15,591
14,930
31,759
13,975
13,281
12,827
12,338
11,806
11,416
10,853
10,504
10,047
11,760
11,146
10,886
9,994
9,594
8,993
8,488
7,753
7,722
6,877
6,228
5,660
4,986
4,497
4,411
4,4114,4974,9865,6606,2286,8777,7227,7538,4888,9939,5949,99410,88611,14611,76010,04710,50410,85311,41611,80612,33812,82713,28113,97531,75914,93015,59115,90716,36517,21817,72418,38818,7596,4906,8956,8156,7747,1837,8127,9982,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,57230301032584131,6131,5961,8732,1503,2672,7042,9803,2573,5343,8114,0884,3644,6414,9185,1955,4722,5948,5988,8749,1519,4283,0823,08210,77011,04611,32311,59911,8763,08212,45312,72212,9912,75613,3459,0629,3342,962000
       Long-term Assets Other 
449
741
731
8,770
2,436
2,581
2,470
12,869
2,279
2,494
2,309
11,212
2,349
2,463
9,081
10,678
6,405
13,087
12,150
6,038
7,248
6,408
5,893
11,244
5,415
5,358
5,525
4,821
3,273
3,198
3,548
3,044
2,966
2,886
2,618
4,083
4,765
1,837
1,783
1,265
1,515
1,460
1,428
1,256
1,277
1,268
1,098
1,095
1,095
1,112
2,144
1,299
1,299
1,455
1,334
1,304
1,275
1,250
1,520
1,217
1,207
1,205
1,205
1,270
1,283
1,424
1,424
1,283
1,283
1,283
1,283
1,214
1,214
1,214
1,214
1,214
1,214
1,214
1,298
1,417
1,440
1,454
1,490
4,123
4,190
4,153
14,192
9,537
12,533
7,922
7,920
4,453
4,419
9,258
11,062
5,667
5,66711,0629,2584,4194,4537,9207,92212,5339,53714,1924,1534,1904,1231,4901,4541,4401,4171,2981,2141,2141,2141,2141,2141,2141,2141,2831,2831,2831,2831,4241,4241,2831,2701,2051,2051,2071,2171,5201,2501,2751,3041,3341,4551,2991,2992,1441,1121,0951,0951,0981,2681,2771,2561,4281,4601,5151,2651,7831,8374,7654,0832,6182,8862,9663,0443,5483,1983,2734,8215,5255,3585,41511,2445,8936,4087,2486,03812,15013,0876,40510,6789,0812,4632,34911,2122,3092,4942,27912,8692,4702,5812,4368,770731741449
> Total Liabilities 
4,534
4,480
5,417
11,262
9,083
9,275
16,391
17,621
15,869
11,126
10,787
11,306
11,364
13,133
29,427
34,834
38,890
28,644
28,795
26,615
73,809
75,573
71,924
72,252
67,935
66,084
66,653
90,345
88,158
89,743
92,132
91,597
90,756
92,069
92,392
80,863
77,409
68,269
70,260
62,849
63,528
61,850
61,696
45,614
38,884
39,383
40,439
40,638
43,837
44,628
45,381
46,693
47,817
38,634
40,547
39,316
45,019
42,555
38,761
51,509
71,065
92,920
165,632
171,500
176,686
179,577
195,881
196,112
194,364
193,972
200,865
214,218
244,049
245,023
261,868
310,946
365,216
368,317
379,679
386,672
382,555
411,748
410,806
426,012
432,864
448,051
402,086
418,049
413,655
442,536
440,855
468,458
465,963
460,354
450,764
462,295
462,295450,764460,354465,963468,458440,855442,536413,655418,049402,086448,051432,864426,012410,806411,748382,555386,672379,679368,317365,216310,946261,868245,023244,049214,218200,865193,972194,364196,112195,881179,577176,686171,500165,63292,92071,06551,50938,76142,55545,01939,31640,54738,63447,81746,69345,38144,62843,83740,63840,43939,38338,88445,61461,69661,85063,52862,84970,26068,26977,40980,86392,39292,06990,75691,59792,13289,74388,15890,34566,65366,08467,93572,25271,92475,57373,80926,61528,79528,64438,89034,83429,42713,13311,36411,30610,78711,12615,86917,62116,3919,2759,08311,2625,4174,4804,534
   > Total Current Liabilities 
2,601
2,778
3,954
8,611
6,819
7,786
15,518
16,207
14,687
9,979
9,683
9,971
9,501
11,342
19,603
22,105
27,925
18,517
20,027
19,204
17,629
20,790
18,324
19,145
14,860
13,207
10,824
9,078
6,993
7,668
8,375
8,383
7,922
8,507
9,079
6,997
6,062
6,639
6,187
5,355
5,774
4,847
40,184
5,416
5,579
4,807
5,865
4,754
5,508
4,588
45,381
4,813
5,778
7,176
9,653
10,296
14,373
18,569
15,610
9,229
20,999
25,321
28,286
28,934
31,258
33,063
34,849
40,851
36,354
32,912
54,407
56,438
30,162
51,317
58,190
68,062
105,511
121,739
132,948
122,209
127,342
142,272
146,895
129,884
138,374
168,754
150,131
156,943
163,062
159,723
173,073
188,952
190,898
204,068
198,356
255,897
255,897198,356204,068190,898188,952173,073159,723163,062156,943150,131168,754138,374129,884146,895142,272127,342122,209132,948121,739105,51168,06258,19051,31730,16256,43854,40732,91236,35440,85134,84933,06331,25828,93428,28625,32120,9999,22915,61018,56914,37310,2969,6537,1765,7784,81345,3814,5885,5084,7545,8654,8075,5795,41640,1844,8475,7745,3556,1876,6396,0626,9979,0798,5077,9228,3838,3757,6686,9939,07810,82413,20714,86019,14518,32420,79017,62919,20420,02718,51727,92522,10519,60311,3429,5019,9719,6839,97914,68716,20715,5187,7866,8198,6113,9542,7782,601
       Short-term Debt 
843
874
906
2,335
2,217
2,441
5,748
5,901
5,384
2,111
1,194
539
285
225
4,305
5,623
5,687
5,304
5,357
5,410
5,464
5,518
5,292
4,126
2,695
1,204
359
146
146
146
146
146
146
146
146
146
146
146
146
146
146
146
32,563
146
146
146
196
198
203
212
210
204
201
2,434
3,259
3,519
4,083
7,429
6,716
1,257
424
146
146
146
146
146
146
146
146
146
19,956
20,640
146
146
146
146
15,001
14,923
15,158
1,993
2,152
3,182
2,995
2,783
3,521
3,096
2,910
3,355
16,889
15,615
15,356
2,518
12,267
12,421
13,136
145,692
145,69213,13612,42112,2672,51815,35615,61516,8893,3552,9103,0963,5212,7832,9953,1822,1521,99315,15814,92315,00114614614614620,64019,9561461461461461461461461461464241,2576,7167,4294,0833,5193,2592,43420120421021220319819614614614632,5631461461461461461461461461461461461461461461463591,2042,6954,1265,2925,5185,4645,4105,3575,3045,6875,6234,3052252855391,1942,1115,3845,9015,7482,4412,2172,335906874843
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,257
0
0
0
146
0
146
146
146
146
139,142
19,956
20,640
146
146
146
146
13,517
13,679
13,847
646
646
1,532
1,182
833
1,463
838
542
728
14,181
13,699
13,458
575
1,022
622
387
146
1463876221,02257513,45813,69914,1817285428381,4638331,1821,53264664613,84713,67913,51714614614614620,64019,956139,14214614614614601460001,25700000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,055
1,024
1,710
2,274
1,970
2,060
3,377
2,948
2,249
1,190
1,398
1,435
843
1,036
1,778
3,180
1,016
1,040
898
2,924
1,021
1,388
1,739
2,590
1,995
2,188
2,209
1,090
661
326
987
674
735
334
699
541
590
717
661
895
431
335
281
699
450
340
504
808
340
632
468
635
582
422
365
835
1,681
930
2,259
1,711
3,973
2,662
3,091
4,489
2,513
5,022
3,268
5,428
4,818
4,572
6,719
8,087
5,407
10,234
11,146
13,624
12,734
19,052
16,424
13,564
14,752
20,698
20,543
17,015
19,477
19,164
25,118
30,486
34,544
41,002
39,711
40,939
46,768
52,473
40,871
61,446
61,44640,87152,47346,76840,93939,71141,00234,54430,48625,11819,16419,47717,01520,54320,69814,75213,56416,42419,05212,73413,62411,14610,2345,4078,0876,7194,5724,8185,4283,2685,0222,5134,4893,0912,6623,9731,7112,2599301,6818353654225826354686323408085043404506992813354318956617175905416993347356749873266611,0902,2092,1881,9952,5901,7391,3881,0212,9248981,0401,0163,1801,7781,0368431,4351,3981,1902,2492,9483,3772,0601,9702,2741,7101,0241,055
       Other Current Liabilities 
703
880
1,338
4,003
2,632
3,284
6,392
7,358
7,053
6,678
7,091
7,996
8,373
10,082
13,520
2,000
10,418
104
9
9
47
47
47
138
898
582
-3,067,400
256
408
877
671
6,149
5,646
6,639
7,004
4,828
3,881
4,341
3,945
2,812
3,649
2,918
6,135
3,031
3,443
2,781
3,615
2,206
3,430
2,505
43,708
2,446
3,467
2,810
4,518
4,282
5,577
7,683
5,446
6,077
7,016
14,736
19,081
20,470
25,443
25,266
28,824
32,666
28,780
25,549
25,503
23,227
23,461
39,991
46,055
52,478
50,536
58,224
67,136
77,478
76,216
81,055
83,239
92,900
92,550
118,341
102,421
110,677
98,102
88,911
105,244
133,226
121,977
131,346
139,355
48,741
48,741139,355131,346121,977133,226105,24488,91198,102110,677102,421118,34192,55092,90083,23981,05576,21677,47867,13658,22450,53652,47846,05539,99123,46123,22725,50325,54928,78032,66628,82425,26625,44320,47019,08114,7367,0166,0775,4467,6835,5774,2824,5182,8103,4672,44643,7082,5053,4302,2063,6152,7813,4433,0316,1352,9183,6492,8123,9454,3413,8814,8287,0046,6395,6466,149671877408256-3,067,4005828981384747479910410,4182,00013,52010,0828,3737,9967,0916,6787,0537,3586,3923,2842,6324,0031,338880703
   > Long-term Liabilities 
1,933
1,702
1,463
2,651
2,264
1,489
873
1,414
1,183
1,146
1,104
1,335
1,863
1,791
9,824
12,729
10,965
10,128
8,768
7,411
56,180
54,783
53,600
53,106
53,075
52,877
55,829
81,267
81,165
82,074
83,757
83,215
82,834
83,562
83,313
73,866
71,347
61,630
64,073
57,494
57,754
57,003
21,513
40,198
33,305
34,577
34,574
35,885
38,329
40,041
40,552
41,880
42,039
31,457
30,894
29,020
30,645
23,986
23,152
42,279
50,066
67,599
137,346
142,567
145,428
146,514
161,032
155,261
158,010
161,059
146,458
157,780
213,887
193,706
203,677
242,884
259,705
246,578
246,731
264,463
255,213
269,476
263,911
296,128
294,490
279,297
251,955
261,106
250,593
282,813
267,782
279,506
275,065
256,286
252,408
206,398
206,398252,408256,286275,065279,506267,782282,813250,593261,106251,955279,297294,490296,128263,911269,476255,213264,463246,731246,578259,705242,884203,677193,706213,887157,780146,458161,059158,010155,261161,032146,514145,428142,567137,34667,59950,06642,27923,15223,98630,64529,02030,89431,45742,03941,88040,55240,04138,32935,88534,57434,57733,30540,19821,51357,00357,75457,49464,07361,63071,34773,86683,31383,56282,83483,21583,75782,07481,16581,26755,82952,87753,07553,10653,60054,78356,1807,4118,76810,12810,96512,7299,8241,7911,8631,3351,1041,1461,1831,4148731,4892,2642,6511,4631,7021,933
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,458
30,921
32,726
33,102
34,991
35,295
35,714
36,148
6,797
6,067
5,348
5,278
0
0
4,769
11,079
11,281
110,553
114,326
118,162
122,125
126,263
130,542
134,157
138,531
123,291
142,385
12,766
12,907
13,054
13,212
53
0
0
13,380
12,584
18,813
18,845
18,879
18,913
18,947
12,786
12,823
0
0
0
12,584
12,627
0
0
0
00012,62712,58400012,82312,78618,94718,91318,87918,84518,81312,58413,380005313,21213,05412,90712,766142,385123,291138,531134,157130,542126,263122,125118,162114,326110,55311,28111,0794,769005,2785,3486,0676,79736,14835,71435,29534,99133,10232,72630,92130,458000000000000000000000000000000000000000000000
       Long term Debt 
1,933
1,702
1,463
2,644
2,264
1,489
873
195
0
0
0
12
0
0
8,082
10,245
8,398
7,408
5,967
4,513
53,042
51,556
50,338
50,044
50,000
50,000
50,000
75,333
75,333
76,347
76,347
77,401
77,401
78,497
78,497
67,836
63,159
48,870
47,966
49,494
49,797
49,193
17,080
34,050
28,722
30,458
30,921
32,726
33,102
34,991
35,295
35,714
36,148
6,797
6,067
5,348
5,278
0
0
4,769
11,079
11,281
110,553
114,326
118,162
122,125
126,263
130,542
134,157
138,531
123,291
142,385
12,766
12,907
13,054
13,212
5,859
0
0
13,380
12,584
18,813
18,845
18,879
18,913
18,947
12,786
12,823
0
0
0
12,584
12,627
12,673
12,720
12,768
12,76812,72012,67312,62712,58400012,82312,78618,94718,91318,87918,84518,81312,58413,380005,85913,21213,05412,90712,766142,385123,291138,531134,157130,542126,263122,125118,162114,326110,55311,28111,0794,769005,2785,3486,0676,79736,14835,71435,29534,99133,10232,72630,92130,45828,72234,05017,08049,19349,79749,49447,96648,87063,15967,83678,49778,49777,40177,40176,34776,34775,33375,33350,00050,00050,00050,04450,33851,55653,0424,5135,9677,4088,39810,2458,08200120001958731,4892,2642,6441,4631,7021,933
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,343
8,530
9,556
9,367
16,228
16,987
16,726
36,015
37,245
37,066
41,268
44,736
50,132
66,488
65,715
65,269
74,102
74,052
75,915
65,098
65,09875,91574,05274,10265,26965,71566,48850,13244,73641,26837,06637,24536,01516,72616,98716,2289,3679,5568,5307,3430000000000000000000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,879
33,398
26,917
26,917
26,917
26,917
26,917
26,917
26,917
22,596
18,275
0
0
0
0
0
0
0
0
0
0
000000000018,27522,59626,91726,91726,91726,91726,91726,91726,91733,39839,879000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
8
0
0
0
1,219
1,183
1,146
1,104
1,323
1,863
1,791
1,742
2,484
2,567
2,720
2,801
2,898
3,138
3,226
3,262
3,063
3,075
2,876
5,830
5,934
5,832
5,728
7,410
5,814
5,433
5,065
4,816
6,030
8,188
12,760
16,107
8,000
7,957
7,809
4,432
6,148
4,583
4,118
3,654
3,159
5,228
5,050
5,257
6,166
5,891
24,660
24,827
23,673
25,368
23,986
23,152
37,511
38,988
56,318
26,793
28,241
27,266
24,389
34,769
24,120
23,323
22,064
22,767
15,061
200,851
180,468
190,444
189,690
220,395
212,375
211,569
216,146
200,356
207,958
202,975
216,201
217,794
207,267
200,269
205,856
203,169
218,241
203,965
191,326
185,670
170,785
0
0
00170,785185,670191,326203,965218,241203,169205,856200,269207,267217,794216,201202,975207,958200,356216,146211,569212,375220,395189,690190,444180,468200,85115,06122,76722,06423,32324,12034,76924,38927,26628,24126,79356,31838,98837,51123,15223,98625,36823,67324,82724,6605,8916,1665,2575,0505,2283,1593,6544,1184,5836,1484,4327,8097,9578,00016,10712,7608,1886,0304,8165,0655,4335,8147,4105,7285,8325,9345,8302,8763,0753,0633,2623,2263,1382,8982,8012,7202,5672,4841,7421,7911,8631,3231,1041,1461,1831,2190008000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,276
1,193
1,080
1,031
945
1,291
1,365
1,473
1,620
1,653
20,479
13,285
20,884
20,096
34,500
21,744
39,947
11,295
13,175
13,066
10,753
21,772
12,374
12,161
11,336
12,446
7,646
12,543
6,173
5,831
5,811
6,584
186,131
180,279
13,033
10,955
17,867
20,494
187,985
10,807
192,439
5,633
3,266
2,585
2,542
2,204
14,700
13,911
180,217
175,379
129,976
129,976175,379180,21713,91114,7002,2042,5422,5853,2665,633192,43910,807187,98520,49417,86710,95513,033180,279186,1316,5845,8115,8316,17312,5437,64612,44611,33612,16112,37421,77210,75313,06613,17511,29539,94721,74434,50020,09620,88413,28520,4791,6531,6201,4731,3651,2919451,0311,0801,1931,276000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,843
2,461
2,079
4,197
4,104
3,966
4,801
4,419
3,949
3,571
3,194
3,148
3,102
3,056
3,010
17,244
16,371
15,498
15,066
14,201
13,636
12,997
12,345
11,692
11,192
10,720
7,748
1,755
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001,7557,74810,72011,19211,69212,34512,99713,63614,20115,06615,49816,37117,2443,0103,0563,1023,1483,1943,5713,9494,4194,8013,9664,1044,1972,0792,4612,843000000000000000000000000000000000000000000000
> Total Stockholder Equity
114,490
110,711
106,681
116,703
110,168
102,597
89,221
75,925
120,620
106,695
93,211
77,757
123,871
108,987
123,015
105,246
142,015
139,185
123,296
106,443
88,174
66,987
49,797
31,899
16,084
3,047
-6,975
-17,393
-25,191
-34,507
-39,496
-47,060
-30,538
-19,929
-29,889
-23,918
-30,698
-28,582
-18,910
-16,975
-24,408
-19,743
-25,080
-14,707
-12,457
-17,152
-16,071
-26,411
-16,212
-16,940
-13,157
-17,600
-22,684
-17,263
-2,877
-4,481
63,285
57,633
48,870
23,018
46,259
87,190
76,976
70,728
44,453
16,877
-21,039
-39,126
8,905
-17,481
-51,594
-75,816
-113,387
-112,707
-130,408
-172,467
-116,134
-157,228
-199,687
-225,356
-195,922
-218,622
-198,488
-203,672
-189,660
-247,118
41,854
34,440
15,718
3,416
-20,385
-61,278
-58,536
-93,195
-129,112
-160,331
-160,331-129,112-93,195-58,536-61,278-20,3853,41615,71834,44041,854-247,118-189,660-203,672-198,488-218,622-195,922-225,356-199,687-157,228-116,134-172,467-130,408-112,707-113,387-75,816-51,594-17,4818,905-39,126-21,03916,87744,45370,72876,97687,19046,25923,01848,87057,63363,285-4,481-2,877-17,263-22,684-17,600-13,157-16,940-16,212-26,411-16,071-17,152-12,457-14,707-25,080-19,743-24,408-16,975-18,910-28,582-30,698-23,918-29,889-19,929-30,538-47,060-39,496-34,507-25,191-17,393-6,9753,04716,08431,89949,79766,98788,174106,443123,296139,185142,015105,246123,015108,987123,87177,75793,211106,695120,62075,92589,221102,597110,168116,703106,681110,711114,490
   Common Stock
248
248
248
273
274
274
290
290
331
331
331
331
394
395
395
395
451
451
455
455
456
456
456
456
458
458
458
458
459
459
476
476
567
658
664
665
671
785
900
900
915
990
993
1,119
1,136
1,143
214
215
228
239
246
246
253
287
353
364
622
627
627
627
708
843
846
864
865
869
871
878
987
996
997
1,017
1,033
1,112
1,184
1,200
1,342
1,373
1,374
1,378
1,633
1,714
1,892
1,961
2,179
2,253
2,475
2,569
2,667
2,829
2,949
3,056
3,417
3,675
3,814
3,944
3,9443,8143,6753,4173,0562,9492,8292,6672,5692,4752,2532,1791,9611,8921,7141,6331,3781,3741,3731,3421,2001,1841,1121,0331,0179979969878788718698658648468437086276276276223643532872532462462392282152141,1431,1361,119993990915900900785671665664658567476476459459458458458458456456456456455455451451395395395394331331331331290290274274273248248248
   Retained Earnings -1,955,668-1,909,378-1,847,177-1,778,161-1,709,907-1,638,814-1,584,592-1,538,158-1,489,833-1,424,322-1,602,874-1,519,584-1,465,907-1,428,300-1,377,147-1,329,667-1,284,993-1,254,938-1,209,464-1,158,830-1,177,311-1,129,557-1,096,431-1,071,760-1,026,476-991,441-954,600-923,643-905,329-879,206-838,429-810,966-779,187-763,580-750,458-710,048-691,306-665,328-657,219-649,178-649,092-643,315-635,996-624,854-619,019-613,579-607,850-600,927-607,695-601,674-596,140-590,382-584,418-582,002-576,295-571,323-562,512-564,372-553,759-541,671-527,337-532,595-521,664-509,710-498,639-491,179-480,393-470,540-461,844-450,307-439,286-425,197-409,963-392,246-374,991-353,863-335,860-318,412-299,937-296,853-279,698-261,642-243,875-227,256-213,764-197,436-183,880-169,775-157,886-144,081-129-91,653-84,346-51,577-46,826-41,980
   Accumulated Other Comprehensive Income 
-1,745
-1,378
-1,317
-1,477
-1,468
-101,111
-1,203
-716
-671
-612
-673
-173
-178
4
40
91
-59
-292
-187
-175
-185
-115
-109
-91
-70
-52
-28
-22
-7
-7
0
-22,628
-22,628
-22,628
-22,628
-25,881
-25,881
0
0
-28,613
-28,965
-29,510
-30,149
-24,993
-25,145
-25,639
-25,941
-26,082
-26,627
-27,170
-27,343
-27,405
-27,389
-27,414
-27,535
-27,637
215
136
-1,157
-1,970
-1,206
-658
-1,332
-2,053
-1,515
-1,658
-1,560
-1,530
-1,661
-2,290
-2,059
-2,169
-2,706
-1,578
-1,616
-1,539
-2,221
-1,079
-1,282
-1,324
-97
369
1,233
2,772
-1,002
260
177
1,492
970
2,149
644
915
917
-717
-1,028
-955
-955-1,028-7179179156442,1499701,492177260-1,0022,7721,233369-97-1,324-1,282-1,079-2,221-1,539-1,616-1,578-2,706-2,169-2,059-2,290-1,661-1,530-1,560-1,658-1,515-2,053-1,332-658-1,206-1,970-1,157136215-27,637-27,535-27,414-27,389-27,405-27,343-27,170-26,627-26,082-25,941-25,639-25,145-24,993-30,149-29,510-28,965-28,61300-25,881-25,881-22,628-22,628-22,628-22,6280-7-7-22-28-52-70-91-109-115-185-175-187-292-5991404-178-173-673-612-671-716-1,203-101,111-1,468-1,477-1,317-1,378-1,745
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
578,169
585,714
581,393
584,811
590,995
594,920
595,917
596,661
618,771
640,409
644,572
711,625
714,089
714,728
715,668
756,804
837,464
841,041
851,104
856,068
856,107
858,855
866,854
933,222
938,412
940,908
951,812
960,047
984,189
999,581
1,005,183
1,043,575
1,051,942
1,055,159
1,059,583
1,132,209
1,156,442
1,226,687
1,257,502
1,328,747
1,353,243
1,463,524
1,520,212
1,550,239
1,583,030
1,614,836
1,644,658
1,715,291
0
0
0
0001,715,2911,644,6581,614,8361,583,0301,550,2391,520,2121,463,5241,353,2431,328,7471,257,5021,226,6871,156,4421,132,2091,059,5831,055,1591,051,9421,043,5751,005,183999,581984,189960,047951,812940,908938,412933,222866,854858,855856,107856,068851,104841,041837,464756,804715,668714,728714,089711,625644,572640,409618,771596,661595,917594,920590,995584,811581,393585,714578,169000000000000000000000000000000000000000000000
   Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-12
-99
-99
-270
-270
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
325
325
325
-325
0
0
0
0
0
0
0
0
0
-13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000-13000000000-325325325325-325-325-325-325-325-325-325-325-325-325-325-325-325-325-325-325-270-270-99-99-120000000000000000000000000000000
   Other Stockholders Equity 
157,940
159,366
160,509
203,719
205,214
106,746
237,979
239,290
296,636
297,818
298,903
291,363
350,912
352,463
384,222
384,458
438,476
438,963
441,440
442,022
441,766
441,637
441,696
441,497
440,893
441,926
442,902
444,014
444,898
445,433
451,207
473,731
501,232
523,704
524,671
528,634
510,302
524,392
544,562
573,250
574,965
585,072
586,078
593,585
601,934
603,483
611,330
607,150
611,114
617,841
627,519
628,578
629,305
645,859
667,619
671,884
711,625
714,089
714,728
715,667
756,804
837,464
841,041
851,104
856,068
856,094
858,855
866,855
933,222
938,412
940,908
951,812
960,047
984,189
999,581
1,005,183
1,010,177
1,025,025
1,028,242
1,032,666
1,105,292
1,129,525
1,199,770
1,230,585
1,306,151
1,334,968
1,025,885
1,054,254
1,550,239
1,583,030
1,614,836
1,231,102
1,715,291
1,751,024
1,777,480
1,792,348
1,792,3481,777,4801,751,0241,715,2911,231,1021,614,8361,583,0301,550,2391,054,2541,025,8851,334,9681,306,1511,230,5851,199,7701,129,5251,105,2921,032,6661,028,2421,025,0251,010,1771,005,183999,581984,189960,047951,812940,908938,412933,222866,855858,855856,094856,068851,104841,041837,464756,804715,667714,728714,089711,625671,884667,619645,859629,305628,578627,519617,841611,114607,150611,330603,483601,934593,585586,078585,072574,965573,250544,562524,392510,302528,634524,671523,704501,232473,731451,207445,433444,898444,014442,902441,926440,893441,497441,696441,637441,766442,022441,440438,963438,476384,458384,222352,463350,912291,363298,903297,818296,636239,290237,979106,746205,214203,719160,509159,366157,940



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue156,314
Cost of Revenue-16,699
Gross Profit139,615139,615
 
Operating Income (+$)
Gross Profit139,615
Operating Expense-299,720
Operating Income-160,105-160,105
 
Operating Expense (+$)
Research Development234,569
Selling General Administrative78,739
Selling And Marketing Expenses13,588
Operating Expense299,720326,896
 
Net Interest Income (+$)
Interest Income0
Interest Expense-97,925
Other Finance Cost-26,855
Net Interest Income-71,070
 
Pretax Income (+$)
Operating Income-160,105
Net Interest Income-71,070
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-257,437-62,773
EBIT - interestExpense = -258,030
-257,437
-147,836
Interest Expense97,925
Earnings Before Interest and Taxes (EBIT)-160,105-159,512
Earnings Before Interest and Taxes (EBITDA)-146,517
 
After tax Income (+$)
Income Before Tax-257,437
Tax Provision-0
Net Income From Continuing Ops-282,957-257,437
Net Income-245,761
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses316,419
Total Other Income/Expenses Net-97,33271,070
 

Technical Analysis of Agenus Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Agenus Inc. The general trend of Agenus Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Agenus Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Agenus Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 3.307 > 3.0122 > 2.9341.

Tweet this
Agenus Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Agenus Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Agenus Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Agenus Inc. The current macd is 1.28806781.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Agenus Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Agenus Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Agenus Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Agenus Inc Daily Moving Average Convergence/Divergence (MACD) ChartAgenus Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Agenus Inc. The current adx is 37.24.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Agenus Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Agenus Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Agenus Inc. The current sar is 1.4356503.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Agenus Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Agenus Inc. The current rsi is 66.53. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Agenus Inc Daily Relative Strength Index (RSI) ChartAgenus Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Agenus Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Agenus Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Agenus Inc Daily Stochastic Oscillator ChartAgenus Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Agenus Inc. The current cci is 95.48.

Agenus Inc Daily Commodity Channel Index (CCI) ChartAgenus Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Agenus Inc. The current cmo is 29.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Agenus Inc Daily Chande Momentum Oscillator (CMO) ChartAgenus Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Agenus Inc. The current willr is -48.24063564.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Agenus Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Agenus Inc Daily Williams %R ChartAgenus Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Agenus Inc.

Agenus Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Agenus Inc. The current atr is 0.86897493.

Agenus Inc Daily Average True Range (ATR) ChartAgenus Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Agenus Inc. The current obv is -65,846,200.

Agenus Inc Daily On-Balance Volume (OBV) ChartAgenus Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Agenus Inc. The current mfi is 22.73.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Agenus Inc Daily Money Flow Index (MFI) ChartAgenus Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Agenus Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Agenus Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Agenus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.532
Ma 20Greater thanMa 501.957
Ma 50Greater thanMa 1001.191
Ma 100Greater thanMa 2000.953
OpenGreater thanClose5.360
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Agenus Inc with someone you think should read this too:
  • Are you bullish or bearish on Agenus Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Agenus Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Agenus Inc

I send you an email if I find something interesting about Agenus Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Agenus Inc.

Receive notifications about Agenus Inc in your mailbox!